Eone Diagnomics Genome Center Co (XKRX:245620) Total Liabilities : ₩122,226 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Total Liabilities?

Eone Diagnomics Genome Center Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩122,226 Mil.

Eone Diagnomics Genome Center Co's quarterly Total Liabilities declined from Sep. 2023 (₩165,443.72 Mil) to Dec. 2023 (₩134,407.50 Mil) and declined from Dec. 2023 (₩134,407.50 Mil) to Mar. 2024 (₩122,226.48 Mil).

Eone Diagnomics Genome Center Co's annual Total Liabilities increased from Dec. 2021 (₩127,942.82 Mil) to Dec. 2022 (₩159,175.17 Mil) but then declined from Dec. 2022 (₩159,175.17 Mil) to Dec. 2023 (₩134,407.50 Mil).

Eone Diagnomics Genome Center Co Total Liabilities Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Total Liabilities Chart

Eone Diagnomics Genome Center Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

48,588.55

90,291.88

127,942.82

159,175.17

134,407.50

Eone Diagnomics Genome Center Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															171,687.87	179,914.94	165,443.72	134,407.50	122,226.48

Eone Diagnomics Genome Center Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eone Diagnomics Genome Center Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	87548.444	+	(39918.763	+	6940.29
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	134,407

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	173518.949	-	39111.452
	=	134,407

Eone Diagnomics Genome Center Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	75517.748	+	(0	+	46708.735
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	122,226

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	164094.5	-	41868.018
	=	122,226

Eone Diagnomics Genome Center Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014

Website

http://www.edgc.com

Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines